Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And the oldest!
Has everyone taken the time to review and research the new CFO Farrell?
$AMBS the moment is near!
Wow..... Game changer!
Does this mean you'll leave this board for the next 6 years?
It depends from which eyes you're looking through.
Hey I resemble that remark!
I would be lying if I said I don't watch the PPS every day (Human Nature) but I spend more time watching for red flags. Everything I have seen and heard has been very impressive and thus deserves my long position, so for now I'm enjoying the ride.... We have been picking up steam since late last year and my opinion is this will continue!
Well said Warp!! Rome was not built in a day....
And Lympro should be FDA approved by then!
Why are you here?
Nice find BTW.
So they have 15 days to get it in.
"A WATCHED POT NEVER BOILS"
Thanks Warp, I thought that guy was full of it from the get go "fantasy Island"
Zoom, I can't PM but interesting... Ty
WH is an insider but is old school doesn't get Twitter....
Gotcha, thanks!
I don't know how many people are like me but I'm self insured and I would want to know at the very least to allow me to prepare the future for my dependents? Like I said before I assume BD is the partner just working out the details one of them being BD wants in on future indications for Lympro!
GLMF
Dead on, bravo Warp!
Good points Risk, my opinion and opinion only BH is that a deal with BD is almost done. it is easy for both sides to crunch number because numbers don't lie, I feel they are hashing out future deals IE Nueropro/ TBI tests BD wants in on those as well? We'll see.....
Back in Amgen's early days it's stock would be .72 a month later it would .75 a month later it would be .68... If you believe in your research and believe in AMBS you ignore the chatter and stay long/strong... It was easier back then we had no message boards and a internet that took to long to sign on... So I guess GC said it best if you can't stand the heat(the negative chatter) get out of the kitchen (AMBS). Good luck All!
Me thinks fantasy ......
Calm, believe it or not it is for some... " they walk among us"
I feel like I'm seven and it's December 21st! #can'twait
I thought I saw something back in January that it would be ready 1H 2014 but maybe it was 2H 2014..... Ty
Zoom, aren't we waiting for the toxicology report that could be announced any day now?
Not buying it....
She can't wait for the seven year LYMPRO update either! We can spin it anyway we want... ;0)
Milestones & Catalysts
LymPro
• Pilot clinical performance study (1Q-14);
• Clinical Performance study to support CLIA registra7on (1H-14);
• Commercial Launch as a Laboratory-Developed Test (“LDT”) under CLIA (2H- 2014);
MANF
• Preliminary systemic toxicology (PK/PD rela7onship) (1H-14) • Re7ni7s Pigmentosa: func7onal gene7c mouse model (1H-14) • Re7ni7s Pigmentosa: clinical popula7on selec7on (1H-14) • Parkinson’s disease: CED delivery data w/Renishaw (1H-14)
Any day now, to the moon Alice!!!!
Not sure what number Gerald couldn't say no to but I'm almost positive he would have to get John's blessing and that my friend won't happen! This is John's legacy and there is not a number, I believe large enough for John to sell.....
Becton Dickson....
Top Medical Companies To Buy For 2015: Amarantus Bioscience Holdings Inc (AMBS)
Amarantus BioScience Holdings, Inc., formerly Amarantus BioSciences, Inc., incorporated on March 22, 2013, is focuses on developing intellectual property and proprietary technology in order to develop drug candidates and diagnostic blood tests to diagnose and treat human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), owns the intellectual property rights to biomarkers related to oncology and neurodegeneration named BC-SeraPro and NuroPro respectively, has a license to an Alzheimer’s disease blood test named LymPro, and owns a number of proprietary cell lines called PhenoGuard. MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. In December 2012, the Company acquired neurodegenerative diagnostic portfolio from Power3 Medical Products. On March 22, 2013, the Company was merged with into Amarantus Bioscience Inc.
The Company also owns an inventory of 88 cell lines that Amarantus refers to as PhenoGuard Cell Lines. MANF is a protein that corrects protein misfolding. The Company’s MANF product development effort is centered on a therapy for Parkinson’s disease.
Advisors’ Opinion:
[By James E. Brumley]
Judging from the company it’s keeping Green Automotive Co. (OTCMKTS:GACR) may have just made its way into the upper echelon of small cap stock opportunities. The electric car company joins Elite Pharmaceuticals Inc. (OTCBB:ELTP), Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS), and only three other companies as Wall-Street.com’s “Best 6 Stocks” for January of 2014. As one of the top information resources for investors – particularly in terms of information regarding small and micro cap stocks – being named among the site’s top pick is an accolade for AMBS, ELTP, and GACR. Even more impressive is that Green Automotive Co. was the only consumer-goods name among those six. Amarantus Bioscience Holdings and Elite Pharmaceuticals are biotechnology names… an industry that can and often does attract a lot of attention just by the nature of the business. The other three names making the “Best 6? list were an energy explorer, a power-management technology manufacturer, and presc ription/medical food producer. For an electric car manufacturer to make the list speaks quite highly of GACR.
If I were BD I think I would offer Amarantus 50m up front and two more 50m payments when they file for the FDA in 2015 and one more upon approval in exchange for half the profits in the US while Amarantus gets the other half and all of ROW.... What would that do for the stock?
Sol ong from AMBS flipper.... Is this better?
Looks like we're getting ready for TAKE OFF!!!
You mean .60 cents!
Like I have been saying TIC TOC TIC TOC. good bye Sol!
Let the negotiations begin.... Do you think the BOA have seen this movie before, they enjoy this stuff... Game on!!!!
It means they are at the table with someone and this is a gun for protection.... My thoughts only, we'll see....
At their discretion at any PPS, this is bullets in the chamber for negotiations. Something huge is going on with AMBS Behind closed doors... I say it's all good!